Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?
What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 1 minute read Pharma Industry News Imugene’s VAXINIA trial shows promising early results for solid tumours Imugene Limited (ASX: IMU), a prominent player in the immuno-oncology field, has released an encouraging update on its… byPallavi MadhirajuNovember 6, 2023